Privium Fund Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Sell	11,170 -1,000	-8%	-$266K	0.6%	28
2025 Q4	$3M	Hold	12,170	–	–	0.55%	28
2025 Q3	$2.15M	Buy	12,170 +2,850	+31%	+$427K	0.39%	29
2025 Q2	$1.3M	Buy	9,320 +1,810	+24%	+$266K	0.28%	28
2025 Q1	$1.35M	Sell	7,510 -1,740	-19%	-$293K	0.35%	28
2024 Q4	$1.45M	Buy	9,250 +2,900	+46%	+$514K	0.33%	29
2024 Q3	$1.16M	Sell	6,350 -70	-1%	-$13.5K	0.29%	33
2024 Q2	$1.14M	Buy	6,420 +1,920	+43%	+$322K	0.29%	41
2024 Q1	$801K	Sell	4,500 -2,110	-32%	-$293K	0.21%	51
2023 Q4	$826K	Buy	6,610 +1,400	+27%	+$155K	0.23%	48
2023 Q3	$604K	Hold	5,210	–	–	0.18%	53
2023 Q2	$603K	Sell	5,210 -3,470	-40%	-$354K	0.17%	54
2023 Q1	$695K	Hold	8,680	–	–	0.23%	46
2022 Q4	$694K	Buy	8,680 +1,418	+20%	+$105K	0.26%	42
2022 Q3	$512K	Buy	7,262 +2,782	+62%	+$201K	0.19%	62
2022 Q2	$294K	Buy	4,480 +480	+12%	+$29.9K	0.1%	80
2022 Q1	$266K	Buy	+4,000	New	+$250K	0.06%	119